These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 31609745)

  • 1. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
    Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
    Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
    J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
    Bao J; Lv Y; Wang K; Wang Q; Chen Y; Dong Y; Zhu Y; Wang W
    J Ultrasound Med; 2023 Jul; 42(7):1481-1489. PubMed ID: 36583414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
    Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
    Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
    Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.
    Dioguardi Burgio M; Castera L; Oufighou M; Rautou PE; Paradis V; Bedossa P; Sartoris R; Ronot M; Bodard S; Garteiser P; Van Beers B; Valla D; Vilgrain V; Correas JM;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1005-1013.e27. PubMed ID: 38072287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Ultrasound Shear Wave Elastography Techniques as Novel Imaging-Based Approaches for Quantitative Evaluation of Hepatic Steatosis-Preliminary Findings.
    Platz Batista da Silva N; Scharf G; Lürken L; Verloh N; Schleder S; Stroszczynski C; Jung EM; Haimerl M
    Tomography; 2023 Mar; 9(2):681-692. PubMed ID: 36961013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study.
    Bulakci M; Ercan CC; Karapinar E; Aksakal MZT; Aliyev S; Bicen F; Sahin AY; Salmaslioglu A
    Pediatr Radiol; 2023 Jul; 53(8):1629-1639. PubMed ID: 36881143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.
    Wang JH; Ou HY; Yen YH; Hung CH; Lu SN
    Liver Int; 2023 Sep; 43(9):1901-1908. PubMed ID: 37249034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    Hsu PK; Wu LS; Su WW; Su PY; Chen YY; Hsu YC; Yen HH; Wu CL
    PLoS One; 2021; 16(10):e0254892. PubMed ID: 34653177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
    Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
    BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
    Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
    J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
    Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
    Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
    Kwon EY; Kim YR; Kang DM; Yoon KH; Lee YH
    Clin Imaging; 2021 Aug; 76():53-59. PubMed ID: 33549920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.